|
View results for a demographic group: |
Select a different topic: |
| View results for a different geographical area: |
|
| Total Respond.^ |
Yes | Yes, during pregnancy | No | No, borderline diabetes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
| TOTAL | 4,277 | 607 | 11.8 | 10.8-12.9 | 34 | 0.9 | 0.6- 1.3 | 3,527 | 84.6 | 83.4-85.8 | 109 | 2.6 | 2.1- 3.3 |
| GENDER | |||||||||||||
| Male | 1,998 | 254 | 10.7 | 9.4-12.2 | *** | *** | *** | 1,697 | 87.0 | 85.3-88.5 | 47 | 2.3 | 1.6- 3.2 |
| Female | 2,279 | 353 | 12.9 | 11.4-14.5 | 34 | 1.7 | 1.2- 2.5 | 1,830 | 82.5 | 80.6-84.2 | 62 | 2.9 | 2.2- 3.9 |
| Have Health Insurance | |||||||||||||
| Yes | 3,720 | 557 | 12.7 | 11.6-14.0 | 29 | 0.9 | 0.6- 1.3 | 3,039 | 83.8 | 82.5-85.1 | 95 | 2.5 | 2.0- 3.2 |
| No | 549 | 49 | 6.7 | 4.9- 9.1 | *** | *** | *** | 482 | 89.4 | 86.2-91.9 | *** | *** | *** |
| Body Mass Index | |||||||||||||
| Underweight | 65 | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Recommended Range | 1,085 | 79 | 6.2 | 4.7- 8.1 | *** | *** | *** | 984 | 91.7 | 89.6-93.4 | 15 | 1.3 | 0.7- 2.3 |
| Overweight | 1,405 | 177 | 10.3 | 8.7-12.1 | *** | *** | *** | 1,187 | 86.2 | 84.1-88.1 | 31 | 2.5 | 1.7- 3.8 |
| Obese | 1,307 | 297 | 19.2 | 16.9-21.6 | *** | *** | *** | 944 | 75.8 | 73.1-78.3 | 55 | 4.3 | 3.1- 5.8 |
| Current Smoker | |||||||||||||
| Yes | 679 | 72 | 8.2 | 6.4-10.5 | *** | *** | *** | 588 | 88.3 | 85.3-90.7 | 16 | 3.1 | 1.7- 5.4 |
| No | 3,442 | 513 | 12.7 | 11.5-14.0 | 31 | 1.1 | 0.7- 1.5 | 2,808 | 83.7 | 82.3-85.0 | 90 | 2.6 | 2.0- 3.3 |
| History of CVD** | |||||||||||||
| Yes | 492 | 176 | 35.2 | 30.3-40.4 | *** | *** | *** | 296 | 60.8 | 55.5-65.8 | 20 | 4.0 | 2.4- 6.4 |
| No | 3,749 | 421 | 9.2 | 8.3-10.3 | 34 | 1.0 | 0.7- 1.4 | 3,206 | 87.3 | 86.1-88.5 | 88 | 2.5 | 1.9- 3.1 |
| Binge Drinker | |||||||||||||
| Yes | 514 | 22 | 2.7 | 1.7- 4.2 | *** | *** | *** | 480 | 94.8 | 92.4-96.5 | *** | *** | *** |
| No | 3,440 | 545 | 13.4 | 12.2-14.7 | 26 | 0.9 | 0.6- 1.3 | 2,774 | 82.9 | 81.4-84.3 | 95 | 2.8 | 2.2- 3.6 |
| COPD | |||||||||||||
| Yes | 362 | 101 | 25.6 | 20.7-31.2 | *** | *** | *** | 249 | 70.8 | 65.1-76.0 | *** | *** | *** |
| No | 3,902 | 502 | 10.6 | 9.6-11.7 | 33 | 1.0 | 0.7- 1.4 | 3,269 | 85.9 | 84.6-87.0 | 98 | 2.6 | 2.0- 3.2 |
| Current Asthma | |||||||||||||
| Yes | 368 | 87 | 20.5 | 16.4-25.3 | *** | *** | *** | 263 | 73.7 | 68.5-78.4 | 13 | 3.9 | 2.2- 6.9 |
| No | 3,891 | 515 | 11.0 | 10.0-12.2 | 27 | 0.8 | 0.5- 1.1 | 3,253 | 85.7 | 84.4-86.9 | 96 | 2.5 | 2.0- 3.2 |
| Functional Disability | |||||||||||||
| Yes | 1,370 | 350 | 22.0 | 19.6-24.6 | *** | *** | *** | 958 | 72.8 | 69.9-75.5 | 56 | 4.8 | 3.5- 6.6 |
| No | 2,764 | 240 | 7.2 | 6.2- 8.3 | 27 | 1.1 | 0.7- 1.7 | 2,447 | 90.1 | 88.8-91.2 | 50 | 1.6 | 1.2- 2.3 |
| Has two or more chronic diseases† | |||||||||||||
| Yes | 1,330 | 475 | 33.9 | 31.0-37.0 | *** | *** | *** | 806 | 62.3 | 59.2-65.4 | 43 | 3.2 | 2.3- 4.4 |
| No | 2,947 | 132 | 3.6 | 3.0- 4.4 | 28 | 1.0 | 0.7- 1.5 | 2,721 | 92.9 | 91.8-93.9 | 66 | 2.4 | 1.8- 3.2 |
**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.
†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2019 are NOT comparable to 2010
and earlier years.
***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2019 Annual Results Technical Notes for more details.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 09SEP20.
FOLLOW US